NCT04421040View on ClinicalTrials.gov

Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

March 22, 2023

Study Completion Date

March 22, 2023

Conditions
TTR Cardiac Amyloidosis
Interventions
DEVICE

Biotronik Biomonitor 3 implant of device

The Biotronik Biomonitor 3 device will be implanted by the research team physician.

DEVICE

Biotronik Biomonitor 3 explant of device

The Biotronik Biomonitor 3 device will be removed from the patient by the research team physician.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04421040 - Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors | Biotech Hunter | Biotech Hunter